Search

everythinglearnresearchcommunity

for

Search:↓

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

No cure for female pattern hair loss, but various effective treatments exist.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Proper diet management is crucial for phenylketonuria patients to avoid severe health issues.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Hair follicle regeneration is possible but challenging, especially in humans, due to the need for specific cells and a better understanding of how they signal growth.

Fractional Er:YAG laser with PRP is more effective and has fewer side effects than microneedling with PRP for vitiligo.

The treatment combination is effective and generally safe for lung cancer.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

Vitiligo's impact varies widely, affecting both emotions and social life, not just physical symptoms.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.